News

Donahue will serve as president until June 30, 2025, when he will host the AAPOS 2025 annual meeting in Salt Lake City, Utah. He previously had served as vice president since July 2023.

During the month of May, Prevent Blindness will offer fact sheets, videos and other resources for IRD education

This initiative will provide a variety of tools to promote awareness and education, including some resources in both English and Spanish.

Gildeuretinol halts Stargardt disease progression, study results indicate

The company expects to launch the supplement in the US, which features a proprietary blend of ingredients including lutein, zeaxanthin isomers, curcumin and vitamin D3, under the brand name Blink NutriTears early in the third quarter of 2024.

Akari Therapeutics, Ocuphire Pharma, and PharmAbcine are among the companies that have shared their plans for presentations at the ARVO annual conference in Seattle, Washington.

The foundation noted the summit will be held June 25-27 in Mexico City, Mexico, and will feature stakeholders across the eye health landscape with a common goal of eradicating avoidable blindness by 2030.

The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration of the lowest deliverable dose.

The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting diagnoses from clinical notes in electronic health records.

Akari Therapeutics, Ocuphire Pharma, and PharmAbcine are among the companies that have shared their plans for presentations the ARVO annual conference, being held in Seattle, Washington. More companies are expected to announce their presentations in the coming days.

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

At this year's ASCRS meeting in Boston, Massachusetts, Shoham-Hazon, MD provided highlights from his two paper presentations.

The collaboration will bring automated, AI-powered OCT segmentation to MICRON Software Suite.

The Vision Simulator shows disease progression and vision loss simulations for diabetic macular edema, diabetic retinopathy, AMD, XLRP, and achromatopsia.

The WVU Health System Board of Directors recently approved $233.5 million to fund the construction of a multi-center outpatient facility with additional exam and testing rooms.

Cataract simulation platform uses virtual reality to train ophthalmologists

At the 2024 ASCRS meeting, David M. Lubeck detailed highlights from his presentations on the minimally invasive glaucoma surgery (MIGS) space.

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

According to the company, OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA gene.

Annual conference to kick off May 5 in Emerald City.

The system is comprised of 25 miniaturized wireless stimulators with 400 electrodes that are implanted permanently.

At this year's ASCRS meeting in Boston, Massachusetts, Josefina Botta, MD, MSc, discussed her real-world experiences with the RayOne EMV toric lens.

At this year's ASCRS meeting Rom Kandavel, MD, of Colvard-Kandavel Eye Center in Los Angeles, California discussed the paper he presented at the meeting, which focused on IOP lowering and medication burden for patients who received the iStent inject.

SGT-1001 uses its novel gene coding technology for gene integration via transposition. It plans to advance SGT-1001 into the clinic in the first half of 2025.

Shift could lead to changes in the current management of retinal diseases

Rising costs of metabolic agents, particularly those used in the treatment of diabetes, impacts patients and the medical systems, such as Medicare and Medicaid.

The tissue serves as a testing ground for outpatient ocular therapies